Streetbeat News

Price Targets

BCAB

JMP Securities analyst Reni Benjamin has reiterated a 'Market Outperform' rating on BioAtla (NASDAQ:BCAB) and maintained a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:21 am

EXEL

JMP Securities analyst Silvan Tuerkcan has reiterated a 'Market Outperform' rating on Exelixis (NASDAQ:EXEL) and maintained a $24 price target.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:21 am

VFC

BMO Capital analyst Simeon Siegel has maintained a 'Market Perform' rating on VF (NYSE:VFC) and lowered the price target from $25 to $22.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:20 am

SEDG

SolarEdge Technologies Inc (NASDAQ:SEDG) reported Q2 financial results, beating estimates on both revenue and EPS. However, the company issued weak Q3 guidance, leading to a drop in its share price and multiple analysts cutting their price targets. SolarEdge expects Q3 revenue to be between $880 million and $920 million, lower than estimates of $1.05 billion.

Portfolio Pulse from Adam Eckert

August 04, 2023 | 11:20 am

WEC

BMO Capital analyst James Thalacker has maintained a 'Market Perform' rating on WEC Energy Group (NYSE:WEC) but lowered the price target from $98 to $95.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:20 am

SWK

Citigroup analyst Eric Lau maintains a Neutral rating on Stanley Black & Decker (NYSE:SWK) and raises the price target from $98 to $110.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:20 am

RYI

BMO Capital analyst Katja Jancic has maintained a 'Market Perform' rating on Ryerson Holding (NYSE:RYI) but lowered the price target from $45 to $40.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:19 am

PEG

BMO Capital's analyst James Thalacker has maintained a 'Market Perform' rating on Public Service Enterprise (NYSE:PEG) but lowered the price target from $66 to $64.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:19 am

PFE

BMO Capital analyst Evan David Seigerman has maintained an 'Outperform' rating on Pfizer (NYSE:PFE) but lowered the price target from $45 to $44.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:19 am

TSX:NBLY

BMO Capital analyst Peter Sklar has maintained a 'Market Perform' rating on Neighbourly Pharmacy (TSX:NBLY) and lowered the price target from C$23 to C$21.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 11:19 am